Posted on 9 月 30, 20249/30/24
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy
Posted on 9 月 7, 20239/7/23
Asset Optimization: Breathe New Life Into Mature Brands with EVERSANA REIGNITE™
Posted on 11 月 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on 10 月 17, 202210/17/22
Developing Best-in-class Copay Programs for Gross-to-Net
Posted on 8 月 4, 20228/4/22
Macroeconomic Factors Impact Cash Flow for Pharma
Posted on 4 月 7, 20224/7/22
Reigniting Revenue for Established Brands
Posted on 4 月 7, 20224/7/22
Reignite Established Brands — Actual Use Case
Posted on 4 月 29, 20214/29/21
Visualizing EVERSANA’s Omnichannel Activation Model
Posted on 4 月 13, 20214/13/21